Source comparison
MOTS-c Compare to Other Research Peptides: Comparison by Research Application
MOTS-c AMPK activation, mitochondrial biogenesis Insulin resistance, metabolic syndrome, mitochondrial dysfunction, age-related metabolic decline Glucose tolerance (GTT), insulin sensitivity (ITT), mitochondrial respiration (OCR), fatty acid oxidation rates 4–
This comparison does not assign a generated winner or score.
- MOTS-c
- AMPK activation, mitochondrial biogenesis
- Insulin resistance, metabolic syndrome, mitochondrial dysfunction, age-related metabolic decline
- Glucose tolerance (GTT), insulin sensitivity (ITT), mitochondrial respiration (OCR), fatty acid oxidation rates
- 4–6 hours (rodent)
- Best choice for metabolic flexibility and mitochondrial function studies. Direct cellular energy pathway modulation
- BPC-157
- Angiogenesis, collagen synthesis, growth factor upregulation
- Tendon/ligament repair, gastric ulcer healing, post-surgical recovery, inflammatory bowel models
- Histology, tensile strength, wound closure rate, vascular density
- 2–4 hours
- Dominant in tissue repair research but no metabolic signaling. Requires imaging or histological analysis
- CJC-1295
- Growth hormone releasing hormone analog, IGF-1 elevation
- Body composition, muscle hypertrophy models, GH deficiency
- Serum GH levels, IGF-1 concentration, lean mass (DEXA), fat mass
- 6–8 days (modified)
- Indirect metabolic effects through GH/IGF-1 axis. Requires frequent blood sampling and expensive assays
- Ipamorelin
- Ghrelin receptor agonist, pulsatile GH release
- Growth hormone studies, appetite regulation, sleep quality models
- GH pulse amplitude, food intake, sleep architecture (EEG)
- 2 hours
- Short half-life requires multiple daily dosing. Often paired with CJC-1295 for sustained effect
- Epithalon
- Telomerase activation, pineal gland modulation
- Cellular aging, circadian rhythm, immune senescence
- Telomere length (qPCR), melatonin levels, immune cell markers
- 2–3 hours
- Aging biomarker research tool. Effects take weeks to months, not suitable for acute intervention studies
- TB-500 (Thymosin Beta-4)
- Actin binding, cell migration, anti-inflammatory
- Wound healing, cardiac repair post-MI, neurological injury
- Wound closure, scar tissue quality, infarct size, motor function tests
- 18–24 hours
- Broader tissue repair profile than BPC-157 but less studied. Longer half-life allows less frequent dosing